AIM IMMUNOTECH INC. Repayments of Long-Term Debt
AIM IMMUNOTECH INC. (AIM) reported Repayments of Long-Term Debt of $122.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-03-31
- AIM IMMUNOTECH INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. repayments of long-term debt for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. repayments of long-term debt for the quarter ending 2021-06-30 was $29.00K, a 67.78% decline year-over-year.
- AIM IMMUNOTECH INC. repayments of long-term debt for the quarter ending 2021-03-31 was $93.00K, a 8.14% increase year-over-year.
- AIM IMMUNOTECH INC. repayments of long-term debt for fiscal 2021 was $122.00K, a 65.63% decline from fiscal 2020.
- AIM IMMUNOTECH INC. repayments of long-term debt for fiscal 2020 was $355.00K, a 4.41% increase from fiscal 2019.
- AIM IMMUNOTECH INC. repayments of long-term debt for fiscal 2019 was $340.00K, a 28.79% increase from fiscal 2018.
- AIM IMMUNOTECH INC. repayments of long-term debt for fiscal 2018 was $264.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $29.00K derived: sum of 3 quarters · filed 2023-03-31 | $122.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $29.00K derived: sum of 2 quarters · filed 2022-11-14 | $122.00K 10-Q · filed 2022-11-14 | $212.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $122.00K 10-Q · filed 2022-08-15 | $212.00K derived: sum of 3 quarters · filed 2022-08-15 | $301.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $93.00K 10-Q · filed 2022-05-13 | $183.00K derived: sum of 2 quarters · filed 2022-05-13 | $272.00K derived: sum of 3 quarters · filed 2022-05-13 | $362.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $179.00K derived: sum of 2 quarters · filed 2022-03-31 | $269.00K derived: sum of 3 quarters · filed 2022-03-31 | $355.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $179.00K derived: sum of 2 quarters · filed 2021-11-15 | $265.00K 10-Q · filed 2021-11-15 | $351.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $176.00K 10-Q · filed 2021-08-16 | $262.00K derived: sum of 3 quarters · filed 2021-08-16 | $347.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $86.00K 10-Q · filed 2021-05-17 | $172.00K derived: sum of 2 quarters · filed 2021-05-17 | $257.00K derived: sum of 3 quarters · filed 2021-05-17 | $342.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $171.00K derived: sum of 2 quarters · filed 2021-03-31 | $256.00K derived: sum of 3 quarters · filed 2021-03-31 | $340.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $170.00K derived: sum of 2 quarters · filed 2020-11-12 | $254.00K 10-Q · filed 2020-11-12 | $337.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $169.00K 10-Q · filed 2020-08-14 | $252.00K derived: sum of 3 quarters · filed 2020-08-14 | $336.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $84.00K 10-Q · filed 2020-05-14 | $167.00K derived: sum of 2 quarters · filed 2020-05-14 | $251.00K derived: sum of 3 quarters · filed 2020-05-14 | $329.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $167.00K derived: sum of 2 quarters · filed 2020-03-30 | $245.00K derived: sum of 3 quarters · filed 2020-03-30 | $264.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $162.00K derived: sum of 2 quarters · filed 2019-11-14 | $181.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $97.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $19.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |